SCHEMBL4129959

SCHEMBL4129959

Cc1c(NC(N)=O)cc(F)c(F)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 4/20 0.41
ALDH1A1 P00352 1/20 0.37
GAA P10253 2/20 0.35
HTT P42858 2/20 0.35
MAPT P10636 1/20 0.35
GFER P55789 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
MAPK1 P28482 1/20 0.35
POLB P06746 1/20 0.35
IKBKB O14920 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
KDM4E B2RXH2 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
MAP2K2 P36507 1/20 0.34
MAP2K1 Q02750 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1055249 0.85 KIF11 (0.41) KIF11ALDH1A1GAAHTTHDAC1
SCHEMBL30682783 0.74 KIF11 (0.51) KIF11ALDH1A1GAAHTTMAPT
SCHEMBL1781432 0.74 DHFR (0.37) CA1CA2CA9
SCHEMBL13831 0.74 KIF11 (0.51) KIF11ALDH1A1GAAHTTMAPT
SCHEMBL23832033 0.74 KIF11 (0.39) KIF11ALDH1A1HTTMAPTGFER
SCHEMBL23577416 0.71 KDM4E (0.50) KIF11ALDH1A1GAAHTTMAPT
SCHEMBL3694279 0.71 DGAT1 (0.41) HTTHDAC1HDAC6LMNACA1
SCHEMBL30480929 0.71 ALDH1A1 (0.56) KIF11ALDH1A1GAAHTTPOLB
SCHEMBL5325638 0.71 ALDH1A1 (0.56) KIF11ALDH1A1GAAHTTPOLB
SCHEMBL1426650 0.70 RAB9A (0.57) ALDH1A1MAPTLMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090069341-A1 INHIBITORS OF HSP90 CHENE PATRICK 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069341-A1 INHIBITORS OF HSP90 HSP90AB1, HSP90B1, HSP90AA1 KIF11 1953/4885ALDH1A1 2811/4885GAA 224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.